AstraZeneca has begun recalling its COVID-19 vaccine World. The pharmaceutical company said there was a glut of updated vaccines against the virus, which had led to lower demand. The decision comes days after the European Union suspended sales of Vaxevria after the company admitted it could cause blood clots.
According to a report from TelegraphThe AstraZeneca COVID-19 vaccine is being recalled worldwide. Pharmaceutical stopped selling Vaxevria in the European Union and will do the same in all countries where he requested a registration certificate.
While there are rumors that this decision is due to an EU veto, AstraZeneca notes that withdrawals are made for commercial reasons. The pharmaceutical company said in a press release that there are many updated vaccines against other COVID-19 variants, so There is no point in continuing to sell yours..
“This has resulted in reduced demand for Vaxevria, which is no longer produced or supplied,” the company said. “AstraZeneca has decided to initiate the revocation of the marketing authorization for Vaccevria in Europe. We will now work with regulators and our partners to develop a clear path forward to close this chapter.”
AstraZeneca added that they are proud of the role their vaccine has played in ending the COVID-19 pandemic. In his statement he mentions that Vaxevria saved more than 6.5 million lives in the first year of use. The pharmaceutical company has supplied more than three billion doses worldwide, including Spain, Mexico, Argentina, Brazil and the UK.
AstraZeneca vaccine recall This will be gradual and will happen over the next few months..
AstraZeneca COVID vaccine at center of controversy again
While reports of side effects from the AstraZeneca vaccine are not new, the pharmaceutical company has acknowledged that Vaxevria may cause blood clots. The company voluntarily withdrew its request to sell the product in the European Union from March, which took effect a few days ago.
AstraZeneca faces class action lawsuit due to side effects of its COVID-19 vaccine. In a legal document submitted to the English High Court, the company acknowledged that Vaxevria can, in very rare cases, cause thrombosis with thrombocytopenia syndrome (TCS).
According to an article published in Elsevier, first case of thrombosis caused by the AstraZeneca vaccine in Spain Registered March 14, 2021.
“Vaccine-associated thrombosis with thrombocytopenia syndrome (VATS) is characterized by the presence of single or multiple thromboses, predominantly venous but also arterial, with a certain predilection for unusual sites such as the visceral territory or cerebral venous sinuses.” TST has been associated with non-replicating adenoviral vector vaccines such as the AstraZeneca vaccine or the Janssen vaccine.”
Reportedly TelegraphThere are already 51 cases against AstraZeneca before the High Court. Victims They are demanding compensation of up to 85 million euros for damages. Faced with accusations, the pharmaceutical company denies its vaccine is defective. Although he acknowledges that thrombosis is possible, he does not know the causative mechanism.
Source: Hiper Textual
